Bringing the fundamentals into focus…
Back to Fulgent Genetics, Inc.
How Fulgent Genetics, Inc. stacks up
FLGT · against 425 other Healthcare companies of similar size
Growth
32/ 100
Below the middle of the pack.
Ranked #247 of 426 · scores higher than 41% of peers
Bars: peers in each 10-point band of the growth score48 peers with a growth score of 30–39, including FLGT · Click a bar to see the companies
Why growth scores 32?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings per share growth and 3-year revenue growth, which are weaker than most Healthcare peers.
- The loss per share widened. Earnings per share growth: — vs peer median 9.8%
- slower revenue growth over three years: weaker than 65% of peers. 3-year revenue growth: 1.8% vs peer median 5.8%
- Revenue growth is close to the peer norm. Revenue growth: 6.8% vs peer median 6.1%
Metric by metric
Position: dot = FLGT, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | FLGT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 439 reported | 6.8% | 3.0% | 62% | 33% | |
| Earnings per share growthHigher is better · 221 reported | Not reported | 3.9% | — | — | 33% |
| 3-year revenue growthHigher is better · 416 reported | 1.8% | 3.0% | 46% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around FLGT| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 885M USD | 99 | 33 | |
| 2 | 609M USD | 99 | 91 | |
| 5 | 3.9B HKD (≈$493M) | 98 | 66 | |
| 247 | 6.8B CNY (≈$947M) | 32 | 27 | |
| 247 | 3.7B CNY (≈$520M) | 32 | 42 | |
| 247 | 2.8B CNY (≈$392M) | 32 | 42 | |
| 247 | 838M USD | 32 | 33 | |
| 247 | 533M USD | 32 | 36 | |
| 252 | 2.8B CNY (≈$394M) | 31 | 39 | |
| 252 | 2.2B CNY (≈$310M) | 31 | 39 | |
| 252 | 63.5B JPY (≈$432M) | 31 | 57 | |
| 252 | 493M USD | 31 | 38 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score